President Commissioner PT Kalbe Farma, Boenyamin Setiawan received Lifetime Achievement Entrepreneur of The Year 2005

Boenjamin Setiawan, widely known as Dr. Boen, has an academic background in both pharmacology and pharmakinetics. He was awarded his PhD in pharmacology in 1961 in the USA. On his return to Indonesia he established a pharmaceutical business working from his own garage and partnering with his siblings who were also active in the medical field.
The success of the Kalbe Farma group under Dr. Boen's leadership has been founded on the local production of cheap generic ethical drugs to meet the economic and health needs of Indonesian people. The strategy is supplemented with alliances with overseas principles and a strong focus on research and development. New product lines have been steadily introduced and international markets developed in Asia and Africa. From very humble beginnings over 30 years ago, the Kalbe Farma group is now the largest pharmaceutical group in Indonesia with over 6000 employees. Around him, Dr. Boen has built a strong management team including his siblings and second generation.

He also enjoys the support and trust of the community, as can be seen from the many social, educational and civic organizations in which he holds key positions and responsibilities, past and present, most notably as Board Member of KOMNAS Lansia, Advisory Board Member of GP Farmasi, Advisory Board Member of KOMNAS Perempuan, Financial Advisor of Yayasan KEHATI, and Treasurer and one of the founders of Yayasan Pengembangan Kreativitas Indonesia. Despite his busy schedule overseeing the operations of the Kalbe Group, he finds time for community services through these organizations and remains active in the Faculty of Pharmacology of the University of Indonesia, where he passes his extensive knowledge in the pharmacology science to his students and colleagues.

Source
http://www.ey.com/GLOBAL/content.nsf/Indonesia/EoY_2005_-_Award_Recipients#Boenjamin_Setiawan

Great News for CAPD ASKES Users in Indonesia

Until now, patients with kidney failure can be managed with Hemodialysis, CAPD and kidney transplant. Among those 3 methods, CAPD (Continuous Ambulatory Peritoneal Dialysis) is currently a hot topic between Asian Nephrologists including Indonesia. This was expressed by Dr. Ginova Nainggolan, SpPD KGH in the Indonesia Nephrology Pre-congress Program on Thursday, November 24th, 2005 in Bali.

In the workshop, CAPD was discussed by speakers such as Prof. DR.Dr. Moch. Sja'bani, SppD KGH MSc, Dr. Tunggul D Situmorang SppD KGH and Prof. DR.Dr. Endang Susalit, SpPD KGH, Dr. Tommy Halauet, SpB.

Dr. Tunggul said, CAPD is very helpful in patients with kidney failure who have to undergo Hemodialysis. The advantage of CAPD is, the patients do not have to use the dialysis machine and may use it by themselves at home. Another advantages are they would have better physical conditions, may exercise as usual and their diet would not be as strict as when they are undergoing hemodialysis.

CAPD has been used in Indonesia since 1984, and according to Prof. Sja'bani at the moment, there are quite a lot of kidney failure patients in Indonesia, and most are from the 3rd class patients (poor people). The government is liable to manage the cost of CAPD through PT ASKES (goverment health assurance), especially for GAKIN (poor people).

In front of 150 participants, Dr. Ita Wijayanti from Kalbe Farma as a speaker explained the usage and function of instruments used in CAPD and the advantage of instruments produced by Baxter - Kalbe, one of them is the diminution of sepsis or peritonitis occurring.


Great News

There is a great news for CAPD Baxter – Kalbe Farma user or users to be, especially ASKES members:

• Free Starter Pack (this particular one has always been free)
• Free for Routine Pack 90 (formerly, participants have to pay Rp. 600.000)
• Only with an additional fee of Rp. 1.033.000 for Routine Pack 120 (a decrease from Rp. 1.600.000)
• The above regulations start October 2005.

Circular Leter Merger Proposal PT Dankos Laboratories Tbk. and PT Enseval into PT KALBE FARMA Tbk.

In relation to the Merger plan, the Board of Directors of the Merger Participants hereby present this Merger Proposal for information to shareholders of each of the Merger Participants, creditors of each of the Merger Participants as well as other relevant parties to the Merger in order to obtain approval from the EGMOS of each Merger Participant to be held on 29 November 2005.


For more information regarding this merger plan, you can click the address below: http://www.kalbefarma.com/files/investor/CircularKalbe.pdf (510 kb)

Promag Double Action, coming soon !!!

As the leader of gastric medication market share in Indonesia (80%), Promag as one of PT Kalbe Farma Tbk brands, does not just sit back, but keep on developing new innovations. Last but not least, PT Kalbe Farma (JSX: KLBF) will launch new variant of Promag, intended for its premium segment.

Promag Double Action works in two-way approach in gastric management. It is the first OTC combine drug in Indonesia, Antacid and Acid Blocker.

In the picture taken after the press conference, from left to right: Rully Prasetyanto (Product Executive), Sinteisa Sunarjo (Group Product Manager), Eliana Taufik (Internist), Mayong Laksono (Moderator), Djoni Hartono (Assistant Director OTC).

According to Eliana, an internist, gastric pains in medical terms is called Dyspepsia Syndrome. Its symptoms are: pain, nausea and even vomiting.


The causes can be divided into two:

1. Organic such as: the presence of stomach ulcer, etc
2. Functional such as: the increase of stomach acid and stomach sensitivity even though the stomach acid remains unchanged, etc.

The gastric pain management itself starts from the diet, a change in lifestyle up to the consumption of medications.

Up to the moment, the circulating Over The Counter drugs are antacids. The function of antacids is to neutralize stomach acid.


Promag Double Action

Promag Double Action works 2 ways, it neutralises and slows down the production of stomach acid or Antagonist H2.


The Submarine Analogy

According to Djoni Hartono, Assistant Director OTC PT Kalbe Farma Tbk, for an easier understanding, gastric pain can be compared with a leaking submarine. If the leakage is small, then it is enough to use a mop to clean the affected area just like using antacids, but if the leakage is getting larger then it needs to be patched, otherwise the submarine will be filled with water. Hence is the purpose of a medication that can suppress the production of stomach acid. The stomach acid suppressant works slowly (therefore it needs to be combined with the antacid that works instantly) but it can work up until 12 hours.

2 Chewable Tablets a Day
Because of Promag’s Double Action long working period, 2 chewable tablets in a day is enough. Unlike a couple of antacid tablets, that have to be consumed 3-4 times day, when the symptoms are quite bad.

BAHASA INDONESIA

CEO of Kalbe Farma received "The Innovation Indonesia Business Leader Award 2005"

Just recently, Mr. Johannes Setijono as CEO of Kalbefarma received "The Innovation Indonesia Business Leader Award 2005" carried out by CNBC Asia and Bank Mandiri.
The event itself was held on September 23rd, 2005.

The judging and selection process was done to 200 Indonesia Business Leaders of 2005, by a line of judges who are highly competent in their fields. It was presided by University of Chicago Graduate Business School as well as some business leaders in Asia.

At the same time, Mr. Budi Dhrama from EPM (Enseval Putra Megatrading) also received an award as one of the finalists in Top 8 Indonesia Business Leader 2005.

About this award

Another award news:
- Kalbe Snatched the Forbes Global Award
- Kalbe Farma is One of the 2003 Indonesia Business Award Winners


BAHASA INDONESIA

Kalbe Farma launched a drug for Endometriosis

Do you suffer from menstrual cramps? Now you can be relieved since PT Kalbe Farma (JSX: KLBF) has marketed a generic product meant for those who have Endometriosis. PT Kalbe Farma’s introduction of Endrolin (product brand) to various print and electronic media was done today in Jakarta. In the picture dr. Antonio Bouzad (a manufacturer from Argentina) is giving Madam Irawati Setiadi (Kalbe Farma) a symbol of Endrolin.

Period Pains
According to dr. Indra Anwar, an Ob-Gyn Specialist from RS Bunda, Menstrual Cramps or Dysmenorrhea is a menstruation disorder suffered by many women. One cause of Dysmenorrhea is Endometriosis or a growth (non-cancer) of endometrium outside the womb. Endometriosis lesion can be found in the Ovaries, Fallopian Tubes and Pelvic Cavity. It can also be found at the Ileum, Colon, Bladder even the Lungs, Spine as well as the Brain. As a result, during a time of menstruation, the areas that have lesions on them will also suffer from hemorrhage.


Endometriosis Treatment
Various ways have been done to treat Endometriosis, some of them include:

1. By giving painkillers
2. By giving medications for the cause
3. Surgery
4. Complementary Therapy

Endrolin / Leuprorelin
Endrolin which contains 3.75mg of Leuprolide Acetate works by depressing the production of Esterogen (female hormone). The hypo-estrogenic condition caused the Endometrium network in and outside the uterus to shrink.

According to an investigation, the hypo-estrogenic condition may decrease symptoms, such as Menstrual Cramps, Abdominal pain and intercourse pain, etc which usually appear because of Endometriosis.

Along with the information acquired from the Press Conference, Endrolin offers women the freedom from conditions caused by Endometriosis including Menstrual Cramps. It also has easy and convenient dosing methods, reversible and light side effects, simple dosage and inexpensive.

BAHASA INDONESIA

Innogene Kalbiotech, a subsidiary of PT Kalbe Farma to penetrate global market

Not only does it wasn’t to be the best in the country but (at the moment "JSX: KLBF" have become the biggest Pharmaceutical company in the Jakarta Stock Exchange), T Kalbe Farma wishes to penetrate the global market, by inventing new products (internationally patented). Hence Indonesia can be proud of the original pharmaceutical drugs produced by PT Kalbe Farma. Through Innogene Kalbiotech, Kalbe Farma will become a drug development companywhich focuses on clinical development. Such is the resolution from the Press Conference held at PT Kalbe Farma’s Marketing Office on Friday, July 29th, 2005.

Innogene Kalbiotech
Innogene Kalbiotech which stands for Innovation Generator Kalbe Farma Biotechnology is a subsidiary of Pt Kalbe Farma, it started on July 8th, 2003. Based on superior science and technology, the company strive to be the best in Pharmaceutical business and invent top products which can penetrate the markets in developed countries. According to Dr Rikrik Ilyas, as Director of Innogene Kalbiotech, besides the drug developments, the company also creates innovative diagnostic equipment which requires scientific and clinical developments in Global Market. From the aspect of class therapy, Innogene specializes itself in the developments of Oncology, Critical Care, Vaccines (therapeutical & preventive) and diagnostics.

Products
Some available Biogeneric products:

1. Hemapo , for the therapy of anemia in dialysis patients caused by kidney failure
2. Kalferon, for chronic Hepatitis B and C patients
3. Fimalbumin, for hypoproteinemia management, with or without edema
4. Fimakinase, for acute miokard infarct therapy, vena cava inferior thrombosis, acute massive lung embolism , acute thrombosis and artery embolism
5. BTXA , for the therapy of strabismus and blepharospasm caused by dystonia
6. Mediflex, a break-through formula to ease topical transdermal arthritis pain
7. Leucogen, a product to ease fever, which is still in evaluation process for patients with non-myeloid under chemotherapy.

BAHASA INDONESIA